Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Deisenhammer

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Clinical aspects and diagnosis of multiple sclerosis]T Berger, F Deisenhammer
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing/remitting multiple sclerosisF Deisenhammer, G Giovannoni
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 2, 2001
Immunoglobulin subclasses in patients with neutralizing and nonneutralizing antibodies against IFN-beta1bF Deisenhammer, M Reindl, T Berger
European Journal of Neurology|June 26, 2003
Evolution of interferon-beta binding antibodies in MS patients may predict development of neutralizing antibodiesM Mayr, K Berek, F Deisenhammer
The New England Journal of Medicine|May 13, 1993
Childhood immunizationsF Deisenhammer, P Pohl, G Grubwieser
European Journal of Neurology|June 17, 2005
Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyelinating diseasesI Mayringer, B Timeltaler, F Deisenhammer
Journal of Neurology, Neurosurgery, and Psychiatry|October 25, 2002
Neutralising antibodies to interferon beta during the treatment of multiple sclerosisG Giovannoni, F E Munschauer, F Deisenhammer
Journal of Neurology, Neurosurgery, and Psychiatry|March 4, 2000
Sensory predominant neuropathy with GM, antibodies, conduction blocks, and orbital pseudotumourS Kiechl, J Willeit, F Deisenhammer, et al.
European Journal of Neurology|November 9, 2017
Cerebrospinal fluid:serum glucose ratio in the ventricular and lumbar compartments: implications for clinical practiceH Hegen, J Walde, M Auer, et al.
Lancet (London, England)|May 5, 1999
Interferon-beta 1b augments activation-induced T-cell death in multiple sclerosis patientsA Kaser, F Deisenhammer, T Berger, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Clinical aspects and diagnosis of multiple sclerosis]T Berger, F Deisenhammer
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing/remitting multiple sclerosisF Deisenhammer, G Giovannoni
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 2, 2001
Immunoglobulin subclasses in patients with neutralizing and nonneutralizing antibodies against IFN-beta1bF Deisenhammer, M Reindl, T Berger
European Journal of Neurology|June 26, 2003
Evolution of interferon-beta binding antibodies in MS patients may predict development of neutralizing antibodiesM Mayr, K Berek, F Deisenhammer
The New England Journal of Medicine|May 13, 1993
Childhood immunizationsF Deisenhammer, P Pohl, G Grubwieser
European Journal of Neurology|June 17, 2005
Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyelinating diseasesI Mayringer, B Timeltaler, F Deisenhammer
Journal of Neurology, Neurosurgery, and Psychiatry|October 25, 2002
Neutralising antibodies to interferon beta during the treatment of multiple sclerosisG Giovannoni, F E Munschauer, F Deisenhammer
Journal of Neurology, Neurosurgery, and Psychiatry|March 4, 2000
Sensory predominant neuropathy with GM, antibodies, conduction blocks, and orbital pseudotumourS Kiechl, J Willeit, F Deisenhammer, et al.
European Journal of Neurology|November 9, 2017
Cerebrospinal fluid:serum glucose ratio in the ventricular and lumbar compartments: implications for clinical practiceH Hegen, J Walde, M Auer, et al.
Lancet (London, England)|May 5, 1999
Interferon-beta 1b augments activation-induced T-cell death in multiple sclerosis patientsA Kaser, F Deisenhammer, T Berger, et al.
Pageof 6